Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rokuro Hama

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|July 14, 2007
Oseltamivir's adverse reactions: Fifty sudden deaths may be related to central suppressionRokuro Hama
BMJ (Clinical Research Ed.)|June 17, 2009
A/H1N1 flu. NSAIDs and fluRokuro Hama
BMJ (Clinical Research Ed.)|April 27, 2022
Imbalance in baseline characteristics in molnupiravir trialsRokuro Hama
Infectious Diseases (London, England)|June 3, 2016
The mechanisms of delayed onset type adverse reactions to oseltamivirRokuro Hama
The New England Journal of Medicine|January 30, 2020
Statins for Familial Hypercholesterolemia from ChildhoodDick Bijl, Rokuro Hama
Lancet (London, England)|October 14, 2015
Oseltamivir for influenzaMark Jones, Rokuro Hama, Chris Del Mar
The Lancet. Respiratory Medicine|June 21, 2014
Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortalityMark Jones, Chris Del Mar, Rokuro Hama
Annals of Internal Medicine|September 5, 2012
Antivirals for treatment of influenzaMark A Jones, Rokuro Hama, Chris Del Mar
Annals of Nutrition & Metabolism|December 11, 2012
Cholesterol issues in Japan--why are the goals of cholesterol levels set so low?Tomohito Hamazaki, Harumi Okuyama, Yoichi Ogushi, et al.
Drug Safety|November 10, 2012
Neuropsychiatric adverse events and oseltamivir for prophylaxisMark Jones, Rokuro Hama, Tom Jefferson, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|July 14, 2007
Oseltamivir's adverse reactions: Fifty sudden deaths may be related to central suppressionRokuro Hama
BMJ (Clinical Research Ed.)|June 17, 2009
A/H1N1 flu. NSAIDs and fluRokuro Hama
BMJ (Clinical Research Ed.)|April 27, 2022
Imbalance in baseline characteristics in molnupiravir trialsRokuro Hama
Infectious Diseases (London, England)|June 3, 2016
The mechanisms of delayed onset type adverse reactions to oseltamivirRokuro Hama
The New England Journal of Medicine|January 30, 2020
Statins for Familial Hypercholesterolemia from ChildhoodDick Bijl, Rokuro Hama
Lancet (London, England)|October 14, 2015
Oseltamivir for influenzaMark Jones, Rokuro Hama, Chris Del Mar
The Lancet. Respiratory Medicine|June 21, 2014
Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortalityMark Jones, Chris Del Mar, Rokuro Hama
Annals of Internal Medicine|September 5, 2012
Antivirals for treatment of influenzaMark A Jones, Rokuro Hama, Chris Del Mar
Annals of Nutrition & Metabolism|December 11, 2012
Cholesterol issues in Japan--why are the goals of cholesterol levels set so low?Tomohito Hamazaki, Harumi Okuyama, Yoichi Ogushi, et al.
Drug Safety|November 10, 2012
Neuropsychiatric adverse events and oseltamivir for prophylaxisMark Jones, Rokuro Hama, Tom Jefferson, et al.
Pageof 3